Literature DB >> 30813871

The impact of SLE on health-related quality of life assessed with SF-36: a systemic review and meta-analysis.

M Gu1,2, Q Cheng1,2, X Wang1,2, F Yuan1,2, N B Sam1,2, H Pan1,2, B Li1,2, D Ye1,2.   

Abstract

OBJECTIVE: To evaluate the impact of systemic lupus erythematosus (SLE) on health-related quality of life (HRQoL) assessed with SF-36 and explore factors associated with HRQoL in SLE patients.
METHODS: A random-effect meta-analysis was performed to calculate extracted data. Sensitivity and subgroup analyses were performed to distinguish sources of heterogeneity.
RESULTS: A total of 36 articles were finally included in this meta-analysis, including 6510 patients. The pooled mean scores of SF-36 physical component summary and mental component summary were 46.10 (95% confidence interval (CI): 43.09-49.10) and 50.37 (95% CI: 47.78-52.87), respectively. Spearman's correlation analysis found that mean age, proportion of female participants, and publication decades were negatively associated with some of the SF-36 domains. Sample size and SLEDAI were positively associated with some of the SF-36 domains. Patients with SLE have lower HRQoL in comparison to the general population.
CONCLUSIONS: SLE has a significant impact on HRQoL, which proves that the necessity of improving HRQoL in SLE patients cannot be ignored. Measuring HRQoL should be considered as an indispensable part of the overall evaluation of health conditions of SLE patients.

Entities:  

Keywords:  Meta-analysis; SF-36; health-related quality of life; systemic lupus erythematosus

Mesh:

Year:  2019        PMID: 30813871     DOI: 10.1177/0961203319828519

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  3 in total

1.  Health-related quality of life, fatigue and health utilities in lupus nephritis: A systematic literature review.

Authors:  Saifuddin Kharawala; Gavneet Kaur; Hemlata Shukla; David Alexander Scott; Neil Hawkins; Wen-Hung Chen; Kerry Gairy
Journal:  Lupus       Date:  2022-05-23       Impact factor: 2.858

2.  Quality of life in lupus erythematosus female patients with cutaneous lesions in Antananarivo, Madagascar.

Authors:  Fandresena Arilala Sendrasoa; Tsiory Iarintsoa Razafimaharo; Léophonte Ramily; Mendrika Fifaliana Rakotoarisaona; Malalaniaina Andrianarison; Onivola Raharolahy; Volatantely Tobiniaina Ratovonjanahary; Naina Harinjara Razanakoto; Irina Mamisoa Ranaivo; Lala Soavina Ramarozatovo; Fahafahantsoa Rapelanoro Rabenja
Journal:  Int J Womens Dermatol       Date:  2021-07-31

3.  EQ-5D-3L full health state discriminates between drug and placebo in clinical trials of systemic lupus erythematosus.

Authors:  Julius Lindblom; Alvaro Gomez; Alexander Borg; Sharzad Emamikia; Dimitris Ladakis; Joaquin Matilla; Martin Pehr; Flordelyn Cobar; Yvonne Enman; Emelie Heintz; Malin Regardt; Ioannis Parodis
Journal:  Rheumatology (Oxford)       Date:  2021-10-02       Impact factor: 7.580

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.